Cognate’s experience going back to 2002 has enabled our team to repeatedly execute complex manufacturing and logistics of personalized cell therapies, allogeneic cell banks, and other gene-mediated cell products.
Cognate understands that one size does not fit all. While quality is at the core of everything we do, it is imperative to be right-sized for the product's current phase of development. This phase-appropriate quality is possible through individual product production lines. Ask us about Phase-appropriate quality and how this can work for you as your product reaches new clinical and commercial milestones.
We offer phase-appropriate services from development through to commercialization in GMP suites supporting materials for supply to the US and EU markets. We offer as little as one production suite all the way to a custom configuration dedicated capacity models for commercial products. Come grow your programs with us.
Let’s talk about how phase-appropriate approach can accelerate your product manufacturing processes!